Preview Mode Links will not work in preview mode

 

Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in digital health and the changing dynamic between doctors and patients.

Topics on the show include

  • the emergence of personalized medicine and breakthroughs in genomics
  • advances in biopharmaceuticals
  • age related diseases and aging in place
  • using big data from wearables and sensors
  • transparency in the medical marketplace
  • challenges for connected health entrepreneurs

The audience includes researchers, medical professionals, patient advocates, entrepreneurs, patients, caregivers, solution providers, students, journalists, and investors.

Nov 2, 2020

Dr. Scott Sigman, orthopedic surgeon and co-founder OrthoLazer Centers has learned how effective the laser can be from his work on acute injuries, chronic inflammatory conditions and around the time of surgery.  As a result, he decided to pursue the idea that laser could be used to treat the cytokine storm in patients...


Nov 2, 2020

Dr. Scott Sigman, orthopedic surgeon and co-founder OrthoLazer Centers has learned how effective the laser can be from his work on acute injuries, chronic inflammatory conditions and around the time of surgery.  As a result, he decided to pursue the idea that laser could be used to treat the cytokine storm in patients...


Aug 19, 2020

Amit Kumar is President and CEO, Anixa Biosciences, a Silicon Valley based biopharmaceutical company focused on the prevention and treatment of cancer and now developing novel treatments for COVID-19. Using high performance computing, molecular modeling and virtual testing techniques, Anixa is focusing exclusively on...


Aug 19, 2020

Amit Kumar is President and CEO, Anixa Biosciences, a Silicon Valley based biopharmaceutical company focused on the prevention and treatment of cancer and now developing novel treatments for COVID-19. Using high performance computing, molecular modeling and virtual testing techniques, Anixa is focusing exclusively on...


Aug 17, 2020

Dr. Cameron Durrant, Chairman and CEO, Humanigen explains the condition called cytokine storm and how their research into GMCSF, the master switch of the cytokine storm, has led to the development of the drug lenzilumab, LENZ, that neutralizes GMCSF. Adding LENZ to Remdesivir has shown promising results in early...